PET/CT imaging in recurrent head and neck cancer

Seminars in Ultrasound CT and MRI

Volumn 24, Issue 3, 2003, Pages 157-163

  Fukui, Melanie B ^a,b   Blodgett, Todd M ^a,b   Meltzer, Carolyn Cidis ^a,b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LIGAND; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; METASTASIS; MINIMAL RESIDUAL DISEASE; MUSCLE CONTRACTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND TUMOR; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SKULL BASE TUMOR; STRUCTURE ANALYSIS; THYROID CANCER; TISSUE METABOLISM; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0038691615     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2171(03)90037-0     Document Type: Article

References (35)

1. Wahl RL, Quint LE, Cieslak RD, et al: "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 34(7):1190-1197, 1993
2. Wong WL, Hussain K, Chevretton E, et al: Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images. Am J Surg 172(6):628-632, 1996
3. Magnani A, Rizzo G, Fazio F, et al: FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg 40:741-748, 1999
4. Sercarz J, Bailet J, Abemayor E, et al: Computer coregistration of positron emission tomography and magnetic resonance images in head and neck cancer. Am J Otolaryngol 19:130-135, 1998
5. Woods R, Cherry S, Mazziotti J: Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16:620-633, 1992
6. Charron M, Beyer T, Kinahan P, et al: Whole-body FDG PET and CT imaging of malignancies using a combined PET/CT scanner. J Nucl Med 40:256P, 1999
7. Charron M, Beyer T, Bohnen N, et al: Image analysis in oncology patients studied with a combined PET/CT scanner. Clin Nucl Med 25:905-910, 2000
8. Townsend D, Beyer T, Kinahan P, et al: Fusion imaging for whole-body oncology with a combined PET and CT scanner. J Nucl Med 40:148P, 1999
9. Lee AW, Law SC, Foo W, et al: Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence [see comments]. Int J Rad Oncol, Biology, Physics 26(5):773-782, 1993
10. Rege SD, Chaiken L, Hoh CK, et al: Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 189(3):807-812, 1993
11. Peterson A, Meltzer C, Evanson E, et al: MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology 211:807-814, 1999
12. DiChiro G, Oldfield E, Wright D, et al: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 150:189-197, 1988
13. Berlangieri SU, Brizel DM, Scher RL, et al: Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head & Neck 16(4):340-346, 1994
14. Anzai Y, Carroll W, Quint D, et al: Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR diagnoses. Radiology 200:135-141, 1996
15. Bailet J, Sercarz J, Abemayor E, et al: The use of positron emission tomography for the early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 105:135-139, 1995
16. Greven K, Williams D, Keyes J, et al: Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Rad Oncol Biol Phys 29:841-845, 1994
17. Greven KM, Williams DW, 3rd, Keyes JW, Jr., et al: Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? [see comments]. Cancer Journal From Scientific American 3(6):353-357, 1997
18. Chaiken L, Rege S, Hoh C, et al: Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Rad Oncol Biol Phys 27(2):455-464, 1993
19. Lapela M, Grenman R, Kurki T, et al: Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluorodeoxy-D-glucose. Radiology 197:205-211, 1995
20. Rege S, Maass A, Chaiken L, et al: Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73:3047-3058, 1994
21. Bailet J, Abemayor E, Jabour B, et al: Positron emission tomography: a new precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 102:281-288, 1992
22. Wong W-L, Chevretton E, McGurk M, et al: A prospective study of PET-FDG imaging for the assessment of head and neck squamous carcinoma. Clin Otolaryngol 22:209-214, 1997
23. Hanasono M, Kunda L, Segall G, et al: Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 109:880-885, 1999
24. Lowe V, Dunphy F, Varvares M, et al: Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F - 18] fluorodeoxyglucose positron emission tomography. Head and Neck 19:666-674, 1997
25. Fukui M, Meltzer C, Snyderman C, et al: Combined PET/CT evaluation of recurrent skull base neoplasm: A new tool. Skull Base 11:17, 2001
26. Abe Y, Matsuzawa T, Fujiwara T, et al: Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 12(7):325-328, 1986
27. Ichiya Y, Kuwabara Y, Otsuka M, et al: Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 32(9): 1655-1660, 1991
28. Minn H, Paul R, Ahonen A: Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 29(9):1521-1525, 1988
29. Stollfuss J, Glatting G, Friess H, et al: 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: Value of quantitative image interpretation. Radiology 195: 339-344, 1995
30. Minn H, Lapela M, Klemi PJ, et al: Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38(12):1907-1911, 1997
31. Keyes JW, Jr., Watson NE, Jr., Williams DW, 3rd, et al: FDG PET in head and neck cancer. AJR Am J Roentgenol 169(6):1663-1669, 1997
32. Greven KM, Williams DW, 3rd, McGuirt WF, Sr., et al: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23:942-946, 2001
33. Jabour BA, Choi Y, Hoh CK, et al: Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation [see comments]. Radiology 186(1):27-35, 1993
34. McGuirt WF, Keyes JW, Jr., Greven KM, et al: Preoperative identification of benign versus malignant parotid masses: A comparative study including positron emission tomography. Laryngoscope 105(6):579-584, 1995
35. Kinahan PE, Townsend DW, Beyer T, et al: Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25(10):2046-2053, 1998